https://crmacademy.co.uk/bariatric-surgery-and-cardiovascular-disease-a-systematic-review-and-meta-analysis/2024-02-22T09:50:20+00:00https://crmacademy.co.uk/bone-marrow-activation-in-response-to-metabolic-syndrome-and-early-atherosclerosis/2024-02-22T09:49:54+00:00https://crmacademy.co.uk/sglt2-inhibitors-in-patients-with-heart-failure-a-comprehensive-meta-analysis-of-five-randomised-controlled-trials/2024-02-22T08:45:55+00:00https://crmacademy.co.uk/polypill-for-prevention-of-cardiovascular-diseases-with-focus-on-non-alcoholic-steatohepatitis-the-polyiran-liver-trial/2024-02-22T08:49:37+00:00https://crmacademy.co.uk/empagliflozin-in-the-treatment-of-heart-failure-with-reduced-ejection-fraction-in-addition-to-background-therapies/2024-02-22T09:08:01+00:00https://crmacademy.co.uk/empagliflozin-and-serum-potassium-in-heart-failure-an-analysis-from-emperor-pooled/2024-02-22T09:12:18+00:00https://crmacademy.co.uk/effects-of-aspirin-on-dementia-and-cognitive-function-in-diabetic-patients-the-ascend-trial/2024-02-22T09:32:06+00:00https://crmacademy.co.uk/dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/2024-02-22T09:35:03+00:00https://crmacademy.co.uk/dapagliflozin-across-the-range-of-ejection-fraction-in-patients-with-heart-failure-a-patient-level-pooled-meta-analysis-of-dapa-hf-and-deliver/2024-02-22T09:38:26+00:00https://crmacademy.co.uk/cardiovascular-and-renal-outcomes-with-efpeglenatide-in-type-2-diabetes/2024-02-22T09:49:04+00:00https://crmacademy.co.uk/the-cardio-renal-metabolic-connection-a-review-of-the-evidence/2024-02-24T09:15:26+00:00https://crmacademy.co.uk/administration-of-metformin-before-meals-may-optimize-its-effects-in-improving-post-prandial-glycemic-control/2024-05-25T09:19:26+01:00https://crmacademy.co.uk/recommended-sodium-fluid-intake-for-hf-patients-by-esc-to-be-1-1-5l-day/2024-05-25T09:20:28+01:00https://crmacademy.co.uk/when-patients-with-heart-failure-are-on-sglt2-inhibition-water-conservation-takes-precedence-over-osmotic-diuresis/2024-05-25T08:58:38+01:00https://crmacademy.co.uk/the-global-burden-diseases-datathe-2023-almanac1990-2023-calls-for-compelling-urgency-for-global-action/2024-05-25T09:08:10+01:00https://crmacademy.co.uk/even-when-low-density-lipoprotein-cholesterol-levels-are-under-strict-control-elevated-lipoproteina-lpa-concentrations-are-linked-to-an-increased-risk-of-cardiovascular-events-however-there-i/2024-05-25T14:50:37+01:00https://crmacademy.co.uk/venturing-the-link-between-cardio-renal-metabolic-diseases/2024-06-11T09:39:14+01:00https://crmacademy.co.uk/empagliflozin-reduces-liver-fat-in-individual-with-or-without-diabetes/2024-06-11T09:38:37+01:00https://crmacademy.co.uk/recommendations-for-treatment-of-hf-in-patients-with-hfref-and-diabetes/2024-05-26T09:15:28+01:00https://crmacademy.co.uk/recommendation-for-diagnosing-diabetes/2024-06-09T13:23:23+01:00https://crmacademy.co.uk/cardiovascular-risk-categories-in-t2d/2024-06-09T13:35:51+01:00https://crmacademy.co.uk/score-2-diabetes-estimating-10-year-cardiovascular-risk/2024-06-09T13:34:11+01:00https://crmacademy.co.uk/recommendation-for-assessing-cardiovascular-risk-in-patient-with-t2d/2024-06-09T13:39:25+01:00https://crmacademy.co.uk/recommendations-for-reducing-weight-in-patient-with-t2d-with-or-without-cvd/2024-06-09T13:41:23+01:00https://crmacademy.co.uk/recommendations-for-reducing-weight-in-patient-with-t2d-with-or-without-cvd-2/2024-06-11T09:52:46+01:00https://crmacademy.co.uk/esc-guidelines-for-treatment-of-hf-patients-with-diabetes/2024-06-09T13:54:20+01:00https://crmacademy.co.uk/management-of-af-in-patients-with-diabetes/2024-06-09T13:56:57+01:00https://crmacademy.co.uk/management-of-cardiovascular-disease-in-patients-with-type-2-diabetes/2024-06-09T14:01:03+01:00https://crmacademy.co.uk/revised-concepts-2023-guidelines/2024-06-09T14:02:14+01:00https://crmacademy.co.uk/recommendation-of-physical-exercise-activity-in-patients-with-t2d-with-or-without-cvd/2024-06-11T09:54:13+01:00https://crmacademy.co.uk/recommendation-for-smoking-cessation-in-patients-with-t2d-with-or-without-cardiovascular-disease/2024-06-11T09:55:01+01:00https://crmacademy.co.uk/recommended-guide-to-glycaemic-targets-in-patients-with-t2d-and-cvd/2024-06-11T09:55:50+01:00https://crmacademy.co.uk/recommendation-for-glycaemic-targets-in-patients-with-diabetes/2024-06-11T09:56:33+01:00https://crmacademy.co.uk/glucose-lowering-treatment-for-patients-with-t2d-to-reduce-cvd-based-on-the-presence-of-atherosclerotic-cvd/2024-06-11T09:57:18+01:00https://crmacademy.co.uk/glucose-lowering-treatment-for-patient-with-t2d-and-atherosclerotic-cardiovascular-disease-to-reduce-cardiovascular-risk/2024-06-11T09:58:03+01:00https://crmacademy.co.uk/recommendation-for-glucose-lowering-treatment-for-patients-with-t2d-and-atherosclerotic-cvd-to-reduce-cvd-risk/2024-06-11T09:58:45+01:00https://crmacademy.co.uk/hypertension-and-diabetes/2024-06-11T09:59:27+01:00https://crmacademy.co.uk/recommendation-for-blood-pressure-management-in-patients-with-diabetes/2024-06-11T10:00:20+01:00https://crmacademy.co.uk/recommendation-for-the-management-of-dyslipidaemia-in-patients-with-diabetes/2024-06-11T10:01:28+01:00https://crmacademy.co.uk/antithrombotic-therapy-and-diabetes/2024-06-11T14:36:34+01:00https://crmacademy.co.uk/recommendation-for-multifactorial-approach-to-risk-factors-management-in-diabetes/2024-06-11T14:40:39+01:00https://crmacademy.co.uk/recommendations-for-a-multifactorial-approach-in-patients-with-type-2-diabetes-with-and-without-cardiovascular-disease/2024-06-11T14:41:32+01:00https://crmacademy.co.uk/recommendation-for-revascularisation-in-patients-with-diabetes/2024-06-11T14:43:04+01:00https://crmacademy.co.uk/crm-quiz/2024-06-23T15:05:03+01:00https://crmacademy.co.uk/crm-fun-quiz-2/2024-06-23T14:48:27+01:00https://crmacademy.co.uk/crm-fun-quiz-2-2/2024-06-23T14:56:58+01:00https://crmacademy.co.uk/crm-fun-quiz-4/2024-06-23T14:58:42+01:00https://crmacademy.co.uk/can-smartphones-identify-patients-with-heart-failure/2024-07-10T08:52:45+01:00https://crmacademy.co.uk/is-there-any-association-between-hdl-c-hdl-p-increased-overall-risk-of-heart-failure/2024-07-10T08:55:42+01:00https://crmacademy.co.uk/crm-fun-quiz-5/2024-07-15T10:49:32+01:00https://crmacademy.co.uk/crm-fun-quiz-6/2024-07-15T11:07:49+01:00https://crmacademy.co.uk/crm-fun-quiz-7/2024-07-15T11:12:27+01:00https://crmacademy.co.uk/crm-fun-quiz-8/2024-07-15T11:17:15+01:00https://crmacademy.co.uk/crm-fun-quiz-9/2024-08-08T04:03:00+01:00https://crmacademy.co.uk/crm-fun-quiz-10/2024-08-08T04:04:41+01:00https://crmacademy.co.uk/crm-fun-quiz-11/2024-08-08T04:05:42+01:00https://crmacademy.co.uk/crm-fun-quiz-12/2024-08-08T04:06:53+01:00https://crmacademy.co.uk/crm-fun-quiz-13/2024-09-14T09:37:27+01:00https://crmacademy.co.uk/crm-fun-quiz-14/2024-09-14T09:42:17+01:00https://crmacademy.co.uk/crm-fun-quiz-14-2/2024-09-14T09:43:07+01:00https://crmacademy.co.uk/crm-fun-quiz-15/2024-09-14T09:43:52+01:00https://crmacademy.co.uk/sglt2i-can-lower-the-risk-of-dementia-in-patients-with-type-2-diabetes-when-compared-with-dpp4-inhibitors/2024-09-14T09:57:44+01:00https://crmacademy.co.uk/treatment-with-sglt2i-after-myocardial-infarction-in-patients-with-type-2-diabetes-is-associated-with-lower-rate-of-cardiovascular-events/2024-09-14T10:06:42+01:00https://crmacademy.co.uk/flow-semaglutide-provides-consistent-cv-benefits-across-the-spectrum-of-kidney-disease/2024-09-14T10:15:12+01:00https://crmacademy.co.uk/finerenone-can-lower-the-rate-of-worsening-heart-failure-events-and-deaths-from-cardiovascular-causes-in-patients-with-mildly-reduced-or-preserved-ejection-fraction/2024-09-14T10:17:31+01:00https://crmacademy.co.uk/obesity-is-a-major-risk-factor-for-cardiovascular-diseases-an-esc-clinical-consensus-statement/2024-09-14T10:19:53+01:00https://crmacademy.co.uk/can-micro-nanoplastics-cause-cardiovascular-diseases/2024-09-14T10:23:51+01:00https://crmacademy.co.uk/is-sglt2i-better-than-glp-1ra-for-preservation-of-renal-function-in-t2d/2024-09-14T10:25:49+01:00https://crmacademy.co.uk/crm-fun-quiz-17/2024-10-10T02:01:38+01:00https://crmacademy.co.uk/crm-fun-quiz-18/2024-10-10T02:02:44+01:00https://crmacademy.co.uk/crm-fun-quiz-19/2024-10-10T02:04:41+01:00https://crmacademy.co.uk/crm-fun-quiz-20/2024-11-04T07:50:33+00:00https://crmacademy.co.uk/crm-fun-quiz-21/2024-11-04T07:52:33+00:00https://crmacademy.co.uk/crm-fun-quiz-21-2/2024-11-04T07:53:07+00:00